logo

Health Care News

Share

Addex's Dipraglurant Blepharospasm Phase 2 Feasibility Clinical Study Fails To Meet Objectives

Phathom Pharma Announces FDA Acceptance For Filing Of Vonoprazan NDA For Erosive Esophagitis

Verrica Gets CRL From FDA For VP-102 NDA For The Treatment Of Molluscum Contagiosum